A problem of persistence: Still more questions than answers?

Nature Reviews Microbiology

Volumn 11, Issue 8, 2013, Pages 587-591

  Balaban, Nathalie Q ^a   Gerdes, Kenn ^b   Lewis, Kim ^c   McKinney, John D ^d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NORTHEASTERN UNIVERSITY   (United States)

^d EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTITOXIN; BACTERICIDE; CIPROFLOXACIN; GUANOSINE 3' DIPHOSPHATE 5' DIPHOSPHATE; ISONIAZID; PENICILLIN BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TOXIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL DIFFERENTIATION; CYSTIC FIBROSIS; DRUG EXPOSURE; ENVIRONMENTAL STRESS; ESCHERICHIA COLI; HUMAN; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STRESS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; HUMANS; MICROBIAL VIABILITY; PHENOTYPE; REACTIVE OXYGEN SPECIES; SPECIES SPECIFICITY; STRESS, PHYSIOLOGICAL;

EID: 84880428168     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3076     Document Type: Review

References (28)

1. Bigger, J. W. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244, 497-500 (1944
2. Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. Bacterial persistence as a phenotypic switch. Science 305, 1622-1625 (2004
3. Rotem, E. et al. Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc. Natl Acad. Sci. USA 107, 12541-12546 (2010
4. Adams, K. N. et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145, 39-53 (2011
5. Amato, S. M., Orman, M. A. & Brynildsen, M. P. Metabolic control of persister formation in Escherichia coli. Mol. Cell 50, 475-487 (2013
6. Gerdes, K. & Maisonneuve, E. Bacterial persistence and toxin-antitoxin loci. Annu. Rev. Microbiol. 66, 103-123 (2012
7. Nguyen, D. et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334, 982-986 (2011
8. Wakamoto, Y. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339, 91-95 (2013
9. Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007
10. Dwyer, D. J., Kohanski, M. A., Hayete, B. & Collins, J. J. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 3, 91 (2007
11. Kohanski, M. A., DePristo, M. A. & Collins, J. J. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell 37, 311-320 (2010
12. Keren, I., Wu, Y., Inocencio, J., Mulcahy, L. R. & Lewis, K. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339, 1213-1216 (2013
13. Liu, Y. & Imlay, J. A. Cell death from antibiotics without the involvement of reactive oxygen species. Science 339, 1210-1213 (2013
14. Mahoney, T. F. & Silhavy, T. J. The Cpx stress response confers resistance to some, but not all, bactericidal antibiotics. J. Bacteriol. 195, 1869-1874 (2013
15. Lewis, K. Persister cells. Annu. Rev. Microbiol. 64, 357-372 (2010
16. Orman, M. A. & Brynildsen, M. P. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 57, 3230-3239 (2013
17. Conan Doyle, A. The Adventures of Sherlock Holmes (George Newnes Ltd, 1892
18. Vega, N. M., Allison, K. R., Khalil, A. S. & Collins, J. J. Signaling-mediated bacterial persister formation. Nature Chem. Biol. 8, 431-433 (2012
19. Wu, Y., Vulic, M., Keren, I. & Lewis, K. Role of oxidative stress in persister tolerance. Antimicrob. Agents Chemother. 56, 4922-4926 (2012
20. Dörr, T., Vulic, M. & Lewis, K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8, e1000317 (2010
21. Dörr, T., Lewis, K. & Vulic, M. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet. 5, e1000760 (2009
22. Johnson, P. J. & Levin, B. R. Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet. 9, e1003123 (2013
23. Mulcahy, L. R., Burns, J. L., Lory, S. & Lewis, K. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192, 6191-6199 (2010
24. Allison, K. R., Brynildsen, M. P. & Collins, J. J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473, 216-220 (2011
25. Pearl, S., Gabay, C., Kishony, R., Oppenheim, A. & Balaban, N. Q. Nongenetic individuality in the host-phage interaction. PLoS Biol. 6, e120 (2008
26. Wexselblatt, E. et al. Relacin, a novel antibacterial agent targeting the stringent response. PLoS Pathog. 8, e1002925 (2012
27. Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69-80 (2010
28. Lestas, I., Vinnicombe, G. & Paulsson, J. Fundamental limits on the suppression of molecular fluctuations. Nature 467, 174-178 (2010